Search

Search Results

• Autologous Stem Cell Transplantation in Primary Refractory Hodgkin’s Lymphoma: Supposed Zugzwang or Zwischenzug?

  Galina Dmitrievna Petrova, K.N. Melkova, T.Z. Chernyavskaya, N.V. Gorbunova, B.V. Afanas’ev, E.A. Demina, V.N. Kostrykina, V.A. Doronin

  321-330

  01.07.2015

• Acute Myeloid Leukemias: 10-Year Therapy Experience

  Ol’ga Yur’evna Baranova, A.S. Antipova, O.D. Zakharov, N.A. Falaleeva, G.I. Kaletin, A.D. Shirin, G.R. Arakelyan, N.N. Tupitsyn, M.A. Frenkel’, N.A. Kupryshina, T.N. Obukhova, E.V. Domracheva, V.B. Larionova, E.V. Ogorodnikova, E.A. Osmanov

  287-301

  01.07.2015

• Multiple Myeloma: 7-Year Experience of Applying Targeted Therapy in Novosibirsk and Its Results

  T.I. Pospelova, Nataliya Valer’evna Skvortsova, I.N. Nechunaeva

  267-273

  01.07.2015

• Mixed-Phenotype Acute Leukemia: Clinical and Laboratory Features, and Prognosis

  A.S. Antipova, Ol’ga Yur’evna Baranova, M.A. Frenkel’, N.N. Tupitsyn, N.A. Kupryshina, T.N. Obukhova, A.D. Shirin

  136-150

  01.04.2015

• Positron Emission Tomography in Modern Management of Lymphomas

  I.P. Aslanidi, Ol’ga Valentinovna Mukhortova, T.A. Katunina, I.V. Ekaeva, M.G. Shavman

  13-25

  01.01.2015

• First Line Treatment Choice for Chronic Myelogenous Leukemia: Modeling of Clinical and Economic Factors

  Vasilii Anatol’evich Shuvaev, K.M. Abdulkadyrov, I.S. Martynkevich, M.S. Fominykh

  78–83

  01.01.2015

• Complex Chromosomal Aberrations in Patients with Post-Transplantation Relapses of Acute Leukemias: Clinical and Theoretical Aspects

  Tat’yana Leonidovna Gindina, N.N. Mamaev, S.N. Bondarenko, N.V. Semenova, E.N. Nikolaeva, M.E. Vlasova, N.V. Stancheva, O.A. Slesarchuk, V.N. Vavilov, E.V. Morozova, A.L. Alyanskii, B.V. Afanas’ev

  69–77

  01.01.2015

• Rationale for Maintenance Treatment of Patients with Acute Myeloid Leukemia below 65 Years of Age, According to Data of a Retrospective Analysis of Protocols AML-2000 and AML-2007

  S.V. Semochkin, T.N. Tolstykh, V.V. Lunin, N.K. Khuazheva, A.I. Kostin, S.A. Chernysh, M.E. Pochtar, V.L. Ivanova

  564-572

  01.10.2014

• Allogeneic Hematopoietic Stem Cell Transplantation for ALL Patients with t(12;21)(p13;q22) Translocation

  N.N. Mamaev, E.V. Semenova, N.V. Stancheva, V.A. Katerina, I.M. Barkhatov, A.V. Evdokimov, E.G. Boychenko, T.L. Gindina, V.M. Kravtsova, L.S. Zubarovskaya, B.V. Afanasyev

  327-334

  01.07.2014

• High-Dose Chemotherapy and Autologous Stem Cells Transplantation for Relapsed/Refractory Hodgkin’s Lymphoma. Is There an Equal Right to Life?

  N.V. Zhukov, A.G. Rumyantsev, A.L. Uss, N.F. Milanovich, V.V. Ptushkin, B.V. Afanasyev, N.B. Mikhaylova, V.B. Larionova, E.A. Demina, E.E. Karamanesht, N.G. Tyurina, M.A. Vernyuk, A.D. Kaprin

  317-326

  01.07.2014

• Management of relapsed and refractory multiple myeloma: literature review and our data. Part III

  S.S. Bessmeltsev

  137-174

  01.04.2014

• Prolonged chemotherapy for angioimmunoblastic T-cell lymphoma

  N.G. Chernova, Yu.E. Vinogradova, Yu.V. Sidorova, I.B. Kaplanskaya, E.A. Gilyazitdinova, L.G. Gorenkova, D.S. Marin, A.M. Kremenetskaya, A.I. Vorobyev, S.K. Kravchenko

  57-62

  01.01.2014

• Radiotherapy in combined treatment of patients with diffuse large B-cell lymphoma

  Yu.N. Vinogradova, N.V. Ilin, D.V. Larionov, M.M. Khodzhibekova, N.A. Kostenikov, L.I. Korytova

  415-420

  01.10.2013

• Multiple myeloma (management of newly diagnosed patients): literature review and our on data. Part II

  S.S. Bessmeltsev

  379-414

  01.10.2013

• Hematopoietic stem cell transplantation in AML patients with t(8;21)(q22;q22) translocation

  N.N. Mamayev, A.V. Gorbunova, T.L. Gindina, I.M. Barkhatov, S.N. Bondarenko, M.Yu. Averyanova, О.V. Pirogova, O.V. Goloshchapov, Ye.V. Kondakova, B.V. Afanasyev

  439-444

  01.10.2013

• Cytogenetic remission as an important criterion for treatment efficacy in pediatric acute myeloid leukemia

  E.W. Fleischman, O.I. Sokova, A.V. Popa, V.S. Nemirovchenko, L.N. Konstantinova, N.F. Metelkova

  148-156

  01.04.2013

• The problem of adherence to therapy in chronic myeloid leukemia: understanding the patient and making a decision

  E.Yu. Chelysheva, A.V. Galaktionova, A.G. Turkina

  157-165

  01.04.2013

• Chimerism following allogeneic hematopoietic stem cell transplantation

  O.V. Blau

  34-39

  01.01.2013